Cargando…
Toward deep learning replacement of gadolinium in neuro-oncology: A review of contrast-enhanced synthetic MRI
Gadolinium-based contrast agents (GBCAs) have become a crucial part of MRI acquisitions in neuro-oncology for the detection, characterization and monitoring of brain tumors. However, contrast-enhanced (CE) acquisitions not only raise safety concerns, but also lead to patient discomfort, the need of...
Autores principales: | Moya-Sáez, Elisa, de Luis-García, Rodrigo, Alberola-López, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406200/ https://www.ncbi.nlm.nih.gov/pubmed/37554645 http://dx.doi.org/10.3389/fnimg.2023.1055463 |
Ejemplares similares
-
DSC MRI in the human brain using deoxyhemoglobin and gadolinium—Simulations and validations at 3T
por: Schulman, Jacob Benjamin, et al.
Publicado: (2023) -
Development and validation of a deep-learning model for detecting brain metastases on 3D post-contrast MRI: a multi-center multi-reader evaluation study
por: Yin, Shaohan, et al.
Publicado: (2022) -
Radiomics and Deep Learning from Research to Clinical Workflow: Neuro-Oncologic Imaging
por: Park, Ji Eun, et al.
Publicado: (2020) -
Locus coeruleus MRI contrast is reduced in Alzheimer's disease dementia and correlates with CSF Aβ levels
por: Betts, Matthew J., et al.
Publicado: (2019) -
Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis
por: Li, Ka-Loh, et al.
Publicado: (2016)